Human–AI Collaboration for Explainable Discovery of Atypical Heart Failure Profiles Through Unsupervised Anomaly Detection and Clinician-Guided Decision Support

Main Article Content

R Pugalenthi
N. Ramshankar
Siva Subramanian R

Abstract

Artificial intelligence (AI) has demonstrated promising capabilities for discovering complex patterns in clinical data; however, meaningful clinical use requires more than autonomous model output. Clinicians must be able to inspect, contextualize, and challenge AI-generated findings before those findings influence patient assessment. This study therefore reframes explainable unsupervised anomaly detection as a human–AI collaboration framework for identifying and interpreting atypical clinical profiles among patients with heart failure. The AI component uses Isolation Forest to discover unusual multidimensional patient profiles without incorporating mortality outcomes during model development, while SHAP-based explanations expose the clinical variables contributing to global and patient-level anomaly patterns. The framework was evaluated using the Heart Failure Clinical Records dataset consisting of 299 patients and 12 clinical variables. The model identified 45 patients (15.1%) as anomalous profiles and 254 patients (84.9%) as non-anomalous profiles. The anomalous subgroup demonstrated a mortality rate of 60.0%, compared with 27.2% among non-anomalous patients, and showed a mortality enrichment ratio of approximately 1.87 relative to the overall cohort. Clinical profile analysis revealed substantially higher creatine phosphokinase and serum creatinine levels among anomalous patients, with fold changes of 2.99 and 1.76, respectively. SHAP analysis identified high blood pressure, sex, creatine phosphokinase, smoking status, ejection fraction, platelet count, age, and serum creatinine as important contributors to anomaly formation. A local explanation further demonstrated an atypical case characterized by preserved ejection fraction together with severe biochemical abnormalities. Within the proposed collaborative workflow, these AI outputs are treated as interpretable evidence for clinician review rather than autonomous diagnoses: the AI highlights unusual patterns and explains them, while the clinician contributes patient context, medical knowledge, and final judgment. Because this retrospective study did not include a clinician user study, the results demonstrate the technical readiness of the framework for human–AI collaboration rather than improved team performance. Future prospective evaluation should examine how clinicians use, verify, and override explainable anomaly findings in real clinical workflows.

Article Details

How to Cite
[1]
R. Pugalenthi, N. Ramshankar, and S. Subramanian R, “Human–AI Collaboration for Explainable Discovery of Atypical Heart Failure Profiles Through Unsupervised Anomaly Detection and Clinician-Guided Decision Support”, Int. J. Appl. Inf. Manag., vol. 6, no. 4, pp. 473–487, Nov. 2026.
Section
Articles